Name | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
---|---|
Synonyms |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine
cc-325 QCR-144 N-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N'-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine ASP 3026 N-[2-(isopropylsulfonyl)phenyl]-N'-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-1,3,5-triazine-2,4-diamine 1,3,5-Triazine-2,4-diamine, N-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N-[2-[(1-methylethyl)sulfonyl]phenyl]- CS-0787 UNII-HP4L6MXF10 N-[2-(Isopropylsulfonyl)phenyl]-N'-{2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl}-1,3,5-triazine-2,4-diamine ASP3026 |
Description | ASP3026 is a novel and selective inhibitor for ALK (anaplastic lymphoma kinase) with IC50 of 3.5 nM. |
---|---|
Related Catalog | |
References |
[1]. Sadao Kuromitsu, et al. AACR 102nd Annual Meeting, 2011. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 794.3±70.0 °C at 760 mmHg |
Molecular Formula | C29H40N8O3S |
Molecular Weight | 580.745 |
Flash Point | 434.2±35.7 °C |
Exact Mass | 580.294434 |
PSA | 127.43000 |
LogP | 1.01 |
Vapour Pressure | 0.0±2.8 mmHg at 25°C |
Index of Refraction | 1.620 |
Storage condition | -20°C |
~85% 1097917-15-1 |
Literature: Astellas Pharma Inc.; OBITSU, Kazuyoshi; AKIBA, Takahiro; KOBAYASHI, Koji; HIRASAWA, Shun; KONDOH, Yutaka; TAKEGUCHI, Kazuhiro; TAKAHAMA, Yuji; ORII, Ryoki Patent: EP2669281 A1, 2013 ; Location in patent: Paragraph 0059 ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
~% 1097917-15-1 |
Literature: EP2669281 A1, ; |
Precursor 9 | |
---|---|
DownStream 0 |